Evidence map›Paper›PMID 36557053›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Safety and Efficacy of the Transaxillary Access for Minimally Invasive Mitral Valve Surgery-A Propensity Matched Competitive Analysis.

Ali Taghizadeh-Waghefi, Sebastian Arzt, Veronica De Angelis, Jana Schiffarth, Asen Petrov, Matuš Tomko, Konstantin Alexiou, Klaus Matschke, Utz Kappert, Manuel Wilbring

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ali Taghizadeh-WaghefiCenter for Minimally Invasive Cardiac Surgery, University Heart Center Dresden, 01307 Dresden, Germany.ORCID 0000-0003-0678-7409
Sebastian ArztCenter for Minimally Invasive Cardiac Surgery, University Heart Center Dresden, 01307 Dresden, Germany.
Veronica De AngelisCenter for Minimally Invasive Cardiac Surgery, University Heart Center Dresden, 01307 Dresden, Germany.
Jana SchiffarthCenter for Minimally Invasive Cardiac Surgery, University Heart Center Dresden, 01307 Dresden, Germany.
Asen PetrovCenter for Minimally Invasive Cardiac Surgery, University Heart Center Dresden, 01307 Dresden, Germany.ORCID 0000-0002-6827-2489
Matuš TomkoDepartment of Cardiac Anesthesiology, University Heart Center Dresden, 01307 Dresden, Germany.
Konstantin AlexiouCenter for Minimally Invasive Cardiac Surgery, University Heart Center Dresden, 01307 Dresden, Germany.
Klaus MatschkeCenter for Minimally Invasive Cardiac Surgery, University Heart Center Dresden, 01307 Dresden, Germany.
Utz KappertCenter for Minimally Invasive Cardiac Surgery, University Heart Center Dresden, 01307 Dresden, Germany.
Manuel WilbringCenter for Minimally Invasive Cardiac Surgery, University Heart Center Dresden, 01307 Dresden, Germany.ORCID 0000-0002-3382-1142

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Transaxillary access is a straightforward “single incision—direct vision” concept, based on a 5 cm skin incision in the right anterior axillary line. It is suitable for aortic, mitral and tricuspid surgery. The present study evaluates the hospital outcomes of the transaxillary access for isolated mitral valve surgery compared with full sternotomy. Patients and Methods: The final study group included 480 patients. A total of 160 consecutive transaxillary patients served as treatment group (MICS-MITRAL). Based on a multivariate logistic regression model including age, sex, body-mass-index, EuroScore II and LVEF, a 1:2 propensity matched control-group (n = 320) was generated out of 980 consecutive sternotomy patients. Redo surgeries, endocarditis or combined procedures were excluded. The mean age was 66.6 ± 10.6 years, 48.6% (n = 234) were female. EuroSCORE II averaged 1.98 ± 1.4%. Results: MICS-MITRAL had longer perfusion (88.7 ± 26.6 min vs. 68.7 ± 32.7 min; p < 0.01) and cross-clamp (64.4 ± 22.3 min vs. 49.7 ± 22.4 min; p < 0.01) times. This did not translate into longer procedure times (132 ± 31 min vs. 131 ± 46 min; p = 0.76). Both groups showed low rates of failed repair (MICS-MITRAL: n = 6/160; 3.75%; Sternotomy: n = 10/320; 3.1%; p = 0.31). MICS-MITRAL had lower transfusion rates (p ≤ 0.001), less re-exploration for bleeding (p = 0.04), shorter ventilation times (p = 0.02), shorter ICU-stay (p = 0.05), less postoperative hemofiltration (p < 0.01) compared to sternotomy patients. No difference was seen in the incidence of stroke (p = 0.47) and postoperative delirium (p = 0.89). Hospital mortality was significantly lower in MICS-MITRAL patients (0.0% vs. 3.4%; p = 0.02). Conclusions: The transaxillary access for MICS-MITRAL provides superior cosmetics and excellent clinical outcomes. It can be performed at least as safely and in the same time frame as conventional mitral surgery by sternotomy.

Indexed as

Cardiac Surgical ProceduresMitral ValveAgedBlood TransfusionFemaleHumansMaleMiddle AgedMinimally Invasive Surgical ProceduresRetrospective StudiesSternotomyTreatment Outcomeminimally invasive mitral valve surgerymitral valveoutcomes

Identifiers

PMID36557053
PMCPMC9785245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.